Enabling low-cost and robust essentiality studies with high-throughput transposon mutagenesis (HTTM)
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283990 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Antoine Champie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Département de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada. Hauptthemen laut MEDLINE: DNA Transposable Elements, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre de recherche du CHUS, Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Transposon-insertion sequencing (TIS) methods couple high density transposon mutagenesis with next-generation sequencing and are commonly used to identify essential or important genes in bacteria. However, this approach can be work-intensive and sometimes expensive depending on the selected protocol. The difficulty to process a high number of samples in parallel using standard TIS protocols often restricts the number of replicates that can be performed and limits the deployment of this technique to large-scale projects studying gene essentiality in various strains or growth conditions. Here, we report the development of a robust and inexpensive High-Throughput Transposon Mutagenesis (HTTM) protocol and validate the method using Escherichia coli strain BW25113, the parental strain of the KEIO collection. HTTM reliably provides high insertion densities with an average of one transposon every ≤20bp along with impressive reproducibility (Spearman correlation coefficients >0.94). A detailed protocol is available at protocol.io and a graphical version is also included with this article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Département de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada.
ORCID-Profile: Sébastien Rodrigue
Förderung
- Centre de recherche du CHUS
- Fonds de Recherche du Québec - Santé
Zitieren
APA
Champie, A., De Grandmaison, A., Jeanneau, S., Grenier, F., Jacques, P. É., & Rodrigue, S. (2023). Enabling low-cost and robust essentiality studies with high-throughput transposon mutagenesis (HTTM). PLOS ONE. https://doi.org/10.1371/journal.pone.0283990
Vancouver
Champie A, De Grandmaison A, Jeanneau S, Grenier F, Jacques PÉ, Rodrigue S. Enabling low-cost and robust essentiality studies with high-throughput transposon mutagenesis (HTTM). PLOS ONE. 2023. doi:10.1371/journal.pone.0283990
BibTeX
@article{Champie2023,
author = {Champie, Antoine and De Grandmaison, Amélie and Jeanneau, Simon and Grenier, Frédéric and Jacques, Pierre-Étienne and Rodrigue, Sébastien},
title = {Enabling low-cost and robust essentiality studies with high-throughput transposon mutagenesis (HTTM)},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283990}
}
EUVIMED